PARP Cancer Research Results

PARP, poly ADP-ribose polymerase (PARP) cleavage: Click to Expand ⟱

Source:

Type:

Poly (ADP-ribose) polymerase (PARP) cleavage is a hallmark of caspase activation. PARP (Poly (ADP-ribose) polymerase) is a family of proteins involved in a variety of cellular processes, including DNA repair, genomic stability, and programmed cell death. PARP enzymes play a crucial role in repairing single-strand breaks in DNA.
PARP has gained significant attention, particularly in the treatment of certain types of tumors, such as those with BRCA1 or BRCA2 mutations. These mutations impair the cell's ability to repair double-strand breaks in DNA through homologous recombination. Cancer cells with these mutations can become reliant on PARP for survival, making them particularly sensitive to PARP inhibitors.
PARP inhibitors, such as olaparib, rucaparib, and niraparib, have been developed as targeted therapies for cancers associated with BRCA mutations.

PARP Family:
The poly (ADP-ribose) polymerases (PARPs) are a family of enzymes involved in a number of cellular processes, including DNA repair, genomic stability, and programmed cell death.
PARP1 is the predominant family member responsible for detecting DNA strand breaks and initiating repair processes, especially through base excision repair (BER).

PARP1 Overexpression:
In several cancer types—including breast, ovarian, prostate, and lung cancers—elevated PARP1 expression and/or activity has been reported.
High PARP1 expression in certain cancers has been associated with aggressive tumor behavior and resistance to therapies (especially those that induce DNA damage).
Increased PARP1 activity may correlate with poorer overall survival in tumors that rely on DNA repair for survival.

Scientific Papers found: Click to Expand⟱

7466-

HNK,

PDT,

MET,

Enhanced integrated therapy for breast cancer employing Honokiol-loaded mesoporous polydopamine nanoparticles in conjunction with photothermal effects and low-dose metformin

-

in-vitro,

BC,

NA

TumCD↓, Dose↝, cl‑Casp3↑, cl‑PARP↑, Apoptosis↑, TumCP↓,

7463-

HNK,

Honokiol Inhibits Colorectal Cancer Cell Growth: Involvement of Hsp27 as a Molecular Target

-

in-vitro,

CRC,

NA

TumCG↓, TumCCA↑, Cyt‑c↑, Apoptosis↑, cl‑PARP↑, Bcl-2↓, HSP27↓,

1286-

HNK,

The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells

-

in-vitro,

CLL,

NA

Apoptosis↑, Casp3↑, Casp8↑, Casp9↑, cl‑PARP↑, Bcl-2↓, BAX↑,

1154-

HNK,

MET,

Honokiol inhibits the growth of hormone-resistant breast cancer cells: its promising effect in combination with metformin

-

in-vitro,

BC,

MCF7

20uM

-

in-vitro,

BC,

SkBr3

12.1± 1.3uM

-

in-vitro,

BC,

MDA-MB-231

17uM

cl‑PARP↑, Bcl-2↓, ERα/ESR1↓,

2073-

HNK,

Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo

-

in-vitro,

OS,

U2OS

21.5 μM

-

in-vivo,

NA,

NA

40 mg/kg

TumCD↑, TumAuto↑, Apoptosis↑, TumCCA↑, GRP78/BiP↑, ROS↑, eff↓, p‑ERK↑, selectivity↑, Ca+2↑, MMP↓, Casp3↑, Casp9↑, cl‑PARP↑, Bcl-2↓, Bcl-xL↓, survivin↓, LC3B-II↑, ATG5↑, TumVol↓, TumW↓, ER Stress↑,

2885-

HNK,

Honokiol: a novel natural agent for cancer prevention and therapy

-

Review,

Var,

NA

NF-kB↓, STAT3↓, EGFR↓, mTOR↓, BioAv↝, Inflam↓, TumCP↓, angioG↓, TumCI↓, TumMeta↓, cSrc↓, JAK1↓, JAK2↓, ERK↓, Akt↓, PTEN↑, ChemoSen↑, chemoP↑, COX2/PTGS2↓, PGE2↓, TNF-α↓, IL1β↓, IL6↓, Casp3↑, Casp8↑, Casp9↑, cl‑PARP↑, DNAdam↑, Cyt‑c↑, RadioS↑, RAS↓, BBB↑, BioAv↓, Half-Life↝, Half-Life↝, toxicity↓,

2867-

HNK,

Honokiol ameliorates oxidative stress-induced DNA damage and apoptosis of c2c12 myoblasts by ROS generation and mitochondrial pathway

-

in-vitro,

Nor,

C2C12

*antiOx↑, *ROS↓, *Bcl-2↑, *BAX↓, Casp9∅, Casp3∅, cl‑PARP∅, Cyt‑c?,

2864-

HNK,

Honokiol: A Review of Its Anticancer Potential and Mechanisms

-

Review,

Var,

NA

TumCCA↑, CDK2↓, EMT↓, MMPs↓, AMPK↑, TumCI↓, TumCMig↓, TumMeta↓, VEGFR2/KDR/Flk1↓, *antiOx↑, *Inflam↓, *BBB↑, *neuroP↑, *ROS↓, Dose↝, selectivity↑, Casp3↑, Casp9↑, NOTCH1↓, cycD1/CCND1↓, cMyc↓, P21?, DR5↑, cl‑PARP↑, P53↑, Mcl-1↑, p65↓, NF-kB↓, ROS↑, JNK↑, NRF2↑, cJun↑, EF-1α↓, MAPK↓, PI3K↓, mTORC1↓, CSCs↓, OCT4↓, Nanog↓, SOX4↓, STAT3↓, CDK4↓, p‑RB1↓, PGE2↓, COX2/PTGS2↓, β-catenin/ZEB1↑, IKKα↓, HDAC↓, HATs↑, H3↑, H4↑, LC3II↑, c-Raf↓, SIRT3↑, Hif1a↓, ER Stress↑, GRP78/BiP↑, cl‑CHOP/DDIT3↑, MMP↓, PCNA↓, Zeb1↓, NOTCH3↓, CD133↓, Nestin↓, ATG5↑, ATG7↑, survivin↓, ChemoSen↑, SOX2↓, OS↑, P-gp/ABCB1↓, Half-Life↓, Half-Life↝, Synergy↑, BioAv↓,

7542-

HT,

Hydroxytyrosol Induces Apoptosis and Cell Cycle Arrest and Suppresses Multiple Oncogenic Signaling Pathways in Prostate Cancer Cells

-

in-vitro,

Pca,

LNCaP

-

in-vitro,

Pca,

C4-2B

-

in-vitro,

Nor,

RWPE-1

TumCP↓, selectivity↑, TumCCA↑, cycD1/CCND1↓, CDK2↓, CDK4↓, Apoptosis↑, Casp↑, cl‑PARP↑, Bax:Bcl2↑, tumCV↓, Akt↓, STAT3↓, NF-kB↓, AR↓, ROS↑, mtDam↑, BioAv↓, toxicity↓, eff↑,

4639-

HT,

Hydroxytyrosol Induces Apoptosis, Cell Cycle Arrest and Suppresses Multiple Oncogenic Signaling Pathways in Prostate Cancer Cells

-

in-vitro,

Pca,

LNCaP

-

in-vitro,

Pca,

C4-2B

TumCP↓, selectivity↑, TumCCA↑, cycD1/CCND1↓, cycE/CCNE↓, CDK2↓, CDK4↓, P21↑, p27/CDKN1B↑, Apoptosis↑, Casp↑, cl‑PARP↑, Bax:Bcl2↑, p‑Akt↓, p‑STAT3↓, NF-kB↓, AR↓, ROS↑, *BioAv↓, *toxicity∅,

7555-

HYP,

RT,

Hyperoside and rutin of Nelumbo nucifera induce mitochondrial apoptosis through a caspase-dependent mechanism in HT-29 human colon cancer cells

-

in-vitro,

Colon,

HT29

tumCV↓, Apoptosis↑, BAX↑, Bcl-2↓, cl‑Casp3↑, cl‑Casp8↑, cl‑Casp9↑, cl‑PARP↑,

7588-

I3C,

Indole-3-carbinol suppresses NF-κB activity and stimulates the p53 pathway in pre-B acute lymphoblastic leukemia cells

-

in-vitro,

AML,

NA

TumCG↓, TumCCA↑, Apoptosis↑, P53↑, P21↑, BAX↑, PUMA↑, NOXA↑, APAF1↑, NF-kB↓, IAP1↓, Bcl-xL↓, Bcl-2↓, XIAP↓, Myc↓, ChemoSen↑, Casp9↑, cl‑PARP↑, eff↑,

7593-

I3C,

Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells

-

Review,

Pca,

NA

Risk↓, TumCG↓, TumCCA↑, P21↑, p27/CDKN1B↑, CDK6↓, cl‑RB1↓, cl‑PARP↑, BAX↑, Bcl-2↓,

7771-

IBC,

Isobavachalcone induces concurrent apoptosis and pyroptosis in anaplastic thyroid cancer cells by modulating the caspase-mediated cleavage of PARP and GSDME

-

vitro+vivo,

Thyroid,

CAL-62

This ROS overload subsequently triggers endoplasmic reticulum (ER) stress and induces mitochondria-mediated apoptosis

TumCG↓, TumCCA↑, Apoptosis↑, Pyro↑, Casp↑, cl‑PARP↑, cl‑GSDME↑, TrxR1↓, ROS↑, ER Stress↑, Dose↝,

7772-

IBC,

Isobavachalcone inhibits acute myeloid leukemia: Potential role for ROS-dependent mitochondrial apoptosis and differentiation

-

vitro+vivo,

AML,

NA

NOD/SCID mice

Apoptosis↑, Diff↑, tumCV↓, TumCP↓, MMP↓, BAX↑, Bcl-2↓, Bcl-xL↓, Mcl-1↓, Cyt‑c↑, cl‑Casp3↑, cl‑Casp9↑, cl‑PARP↑, p‑MEK↑, p‑ERK↑, ROS↑, eff↓,

7774-

IBC,

Isobavachalcone isolated from Psoralea corylifolia inhibits cell proliferation and induces apoptosis via inhibiting the AKT/GSK-3β/β-catenin pathway in colorectal cancer cells

-

in-vitro,

CRC,

HCT116

-

in-vitro,

CRC,

SW480

TumCP↓, Apoptosis↑, cl‑Casp3↑, cl‑PARP↑, Bcl-2↓, BAX↑, XIAP↓, survivin↓, Wnt↓, β-catenin/ZEB1↓, Akt↓, GSK‐3β↓,

7718-

IP6,

Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes

-

in-vitro,

Pca,

DU145

chemoPv↑, TumCG↓, TumCCA↑, P21↓, p27/CDKN1B↑, CDK2↓, CDK4↓, CDK6↓, cycE/CCNE↓, cycD1/CCND1↓, pRB↑, Apoptosis↑, cl‑PARP↑, Casp3↑,

7724-

IP6,

Inositol hexakisphosphate blocks tumor cell growth by activating apoptotic machinery as well as by inhibiting the Akt/NFkappaB-mediated cell survival pathway

-

in-vitro,

Cerv,

HeLa

NF-kB↓, Akt↓, MMP↓, Cyt‑c↑, Apoptosis↑, Casp3↑, Casp9↑, PARP↑, eff↑,

7691-

IP6,

Inositol Hexaphosphate Suppresses Growth and Induces Apoptosis in Prostate Carcinoma Cells in Culture and Nude Mouse Xenograft: PI3K-Akt Pathway as Potential Target

-

vitro+vivo,

Pca,

PC3

-

in-vitro,

Pca,

C4-2B

TumCP↓, Apoptosis↑, Casp3↑, cl‑PARP↑, Akt↓, PI3K↓, p‑GSK‐3β↓, cycD1/CCND1↓, TumVol↓, TumW↓, PCNA↓, angioG↓, CD31/PECAM-1↓, ILK↓, VEGF↓, eNOS↓, Hif1a↓,

7747-

ISL,

Isoliquiritigenin Induces Apoptosis via ROS-Mediated Inhibition of p38/mTOR/STAT3 Pathway in Human Melanoma Cells

-

in-vitro,

Melanoma,

SK-MEL-28

*Inflam↓, *AntiViral↑, *AntiTum↑, *antiOx↑, cl‑Casp9↑, cl‑Casp7↑, cl‑Casp3↑, cl‑PARP↑, BAX↑, Bcl-2↓, Cyt‑c↑, cycD1/CCND1↓, cycD1/CCND1↓, survivin↓, ROS↓, eff↓, p‑mTOR↓, p‑STAT3↓, p‑MAPK↓,

7761-

ISL,

Targeting digestive system cancers with isoliquiritigenin: a comprehensive review of antitumor mechanisms

-

Review,

Var,

NA

Apoptosis↑, TumAuto↑, TumCCA↑, ROS↑, JNK↑, p38↑, STAT3↑, NF-kB↓, IκB↑, Bcl-2↓, BAX↑, cl‑Casp3↑, cl‑PARP↑, P21↑, p27/CDKN1B↑, CycB/CCNB1↑, CDK1↓, CDK2↓, GRP78/BiP↓, PI3K↓, Akt↓, mTOR↓, eff↑, GLUT4↓, lactateProd↓, OXPHOS↓, Glycolysis↓, BioAv↑, ENO1↓, ALDOA↓, LDHA↓, MCT4↓, RadioS↑, Ferroptosis↑, i-Iron↑, BioAv↑, Half-Life↓,

7763-

ISL,

Harnessing Liquiritigenin: A Flavonoid-Based Approach for the Prevention and Treatment of Cancer

-

Review,

Var,

NA

AntiCan↑, *antiOx↓, *Inflam↓, TumCP↓, Apoptosis↑, NF-kB↓, PI3K↓, Akt↓, mTOR↓, *AntiArt↑, Casp8↑, Cyt‑c↑, Casp↑, cl‑PARP↑, GutMicro↑, BioAv↑, BioAv↓, Half-Life↓,

7730-

isoFl,

Anticancer Potential of Isoflavones: A Narrative Overview of Mechanistic Insights and Experimental Evidence from the Past Ten Years

-

Review,

Var,

NA

Apoptosis↑, ROS↓, TumCCA↓, TumCMig↓, TumCI↓, MMP↓, angioG↓, ChemoSen↑, p‑Akt↓, p‑mTOR↓, cl‑PARP↑, cycA1/CCNA1↓, CycB/CCNB1↓, STAT3↓,

7864-

isoO,

Isoorientin Inhibits Amyloid β25-35-Induced Neuronal Inflammation in BV2 Cells by Blocking the NF-κB Signaling Pathway

-

in-vitro,

AD,

BV2

*iNOS↓, *COX2/PTGS2↓, *TNF-α↓, *IL6↓, *ROS↓, *NF-kB↓, *Apoptosis↓, *Bcl-2↑, *BAX↓, *cl‑Casp9↓, *cl‑Casp3↓, *cl‑PARP↓, *NeuroI↓,

7856-

isoO,

Isoorientin induces the apoptosis and cell cycle arrest of A549 human lung cancer cells via the ROS‑regulated MAPK, STAT3 and NF‑κB signaling pathways

-

in-vitro,

Lung,

A549

Bacteria↓, Inflam↓, TumCD↑, selectivity↑, Apoptosis↑, MMP↓, BAX↑, cl‑Casp3↑, PARP↓, Bcl-2↓, TumCCA↑, CycB/CCNB1↓, CDK1↓, CDK2↓, NA↑, p27/CDKN1B↑, ROS↑, eff↓, p‑p38↑, p‑JNK↑, ERK↓, STAT3↓, NF-kB↓,

7855-

isoO,

Isoorientin induces apoptosis and autophagy simultaneously by reactive oxygen species (ROS)-related p53, PI3K/Akt, JNK, and p38 signaling pathways in HepG2 cancer cells

-

in-vitro,

Liver,

HepG2

-

in-vitro,

Nor,

HL7702

TumAuto↑, Beclin-1/ATG6↑, LC3II↑, eff↓, ROS↑, Fas↑, P53↓, PI3K↓, Akt↓, NF-kB↓, Cyt‑c↑, Casp3↑, cl‑PARP↑,

7854-

isoO,

Isoorientin induces apoptosis through mitochondrial dysfunction and inhibition of PI3K/Akt signaling pathway in HepG2 cancer cells

-

in-vitro,

Liver,

HepG2

TumCD↑, selectivity↑, *toxicity↓, cl‑PARP↑, DNAdam↑, Bax:Bcl2↑, MMP↓, Cyt‑c↑, Casp3↑, ROS↑, NO↑, p‑Akt↓, FOXO4↑, eff↓,

7880-

isoO,

Inhibition of ROS-mediated activation Src-MAPK/AKT signaling by orientin alleviates H2O2-induced apoptosis in PC12 cells

-

in-vitro,

Nor,

PC12

*toxicity↓, *Apoptosis↓, *Casp3↓, *PARP↓, *ROS↓,

7866-

isoO,

Orientin and Cancer Suppression: Molecular Mechanisms and Synergistic Effects

-

Review,

Var,

NA

TumCP↓, Apoptosis↑, angioG↓, TumMeta↓, selectivity↑, *toxicity↓, Bax:Bcl2↑, Cyt‑c↑, Diablo↑, Casp9↑, Casp3↑, cl‑PARP↑, DNAdam↑, γH2AX↑, ROS↑, PCNA↓, MMP2↓, MMP9↓, TumCCA↑, cycD1/CCND1↓, CDK4↓, P21↑, NF-kB↓, HH↓, Ki-67↓, COX2/PTGS2↓, TNF-α↓, ChemoSen↑, chemoP↑, eff↑, angioG↓,

7795-

ISQ,

The Flavonol Isoquercitrin Promotes Mitochondrial-Dependent Apoptosis in SK-Mel-2 Melanoma Cell via the PI3K/AKT/mTOR Pathway

-

in-vitro,

Melanoma,

SK-MEL-28

 5, 10, 15, 20, and 25 μM of IQ for 24 h

-

in-vitro,

Nor,

HaCaT

BioAv↑, TumCP↓, selectivity↑, DNAdam↑, Apoptosis↑, TumCCA↑, Bcl-2↓, cl‑PARP↑, BAX↑, AIF↑, Endoglin↑, PI3K↓, Akt↓, mTOR↓,

7794-

ISQ,

Isoquercitrin induces apoptosis and autophagy in hepatocellular carcinoma cells via AMPK/mTOR/p70S6K signaling pathway

-

in-vitro,

Liver,

HepG2

-

in-vitro,

Liver,

HUH7

tumCV↓, Apoptosis↑, TumAuto↑, AMPK↑, TumCG↓, ATG5↑, Beclin-1/ATG6↑, p‑mTOR↓, Casp3↑, cl‑PARP↑, Bax:Bcl2↑, LC3II↑, p62↓,

8025-

IVM,

Ivermectin has New Application in Inhibiting Colorectal Cancer Cell Growth

-

in-vitro,

CRC,

SW480

-

in-vivo,

CRC,

HCT116

*AntiP↓, *Inflam↓, *AntiViral↑, AntiTum↑, TumCP↓, Apoptosis↑, Casp3↑, Casp7↑, BAX↑, cl‑PARP↑, Bcl-2↓, mt-ROS↑, eff↓, Dose↝, TumCCA↑,

8024-

IVM,

Ivermectin induces apoptosis of esophageal squamous cell carcinoma via mitochondrial pathway

-

vitro+vivo,

ESCC,

KYSE-30

 nude mice model

-

in-vitro,

ESCC,

NE3

TumCP↓, mtDam↑, Apoptosis↑, ROS↑, NF-kB↓, Bax:Bcl2↑, LDH↝, TumCCA↑, cl‑Casp9↑, cl‑Casp3↑, cl‑PARP↑, eff↓,

8043-

IVM,

Ivermectin suppresses tumour growth and metastasis through degradation of PAK1 in oesophageal squamous cell carcinoma

-

vitro+vivo,

ESCC,

KYSE-30

-

in-vitro,

ESCC,

KYSE70

-

in-vitro,

ESCC,

KYSE150

tumCV↓, Apoptosis↑, TumCMig↓, TumCI↓, MMP2↓, MMP9↓, PAK1↓, ChemoSen↑, cl‑PARP↑, Casp3↑, TumMeta↓,

8039-

IVM,

Ivermectin-Induced Apoptotic Cell Death in Human SH-SY5Y Cells Involves the Activation of Oxidative Stress and Mitochondrial Pathway and Akt/mTOR-Pathway-Mediated Autophagy

-

in-vitro,

neuroblastoma,

SH-SY5Y

*toxicity↑, TumCD↑, ROS↑, mtDam↑, Apoptosis↑, MitoP↑, TumAuto↑, p‑Akt↓, p‑mTOR↓, LC3II↑, Beclin-1/ATG6↑, ATG5↑, PINK1↑, PARK2↑, tumCV↓, MDA↑, SOD↑, Catalase↑, eff↓, MMP↓, BAX↑, cl‑Casp3↑, cl‑Casp9↑, cl‑PARP↑, Cyt‑c↑, Bcl-2↓, proCasp3↓, Bax:Bcl2↑, eff↑, *AntiP↑, *Inflam↓, *AntiDiabetic↑, *AntiViral↑, BBB∅, toxicity↝,

7893-

IVT,

Isovitexin (IV) induces apoptosis and autophagy in liver cancer cells through endoplasmic reticulum stress

-

vitro+vivo,

Liver,

NA

TumCG↓, Apoptosis↑, BAX↑, cl‑Casp3↑, cl‑PARP↑, Cyt‑c↑, TumAuto↑, LC3II↑, ATG3↑, ATG5↑, Beclin-1/ATG6↑, ER Stress↑, IRE1↑, XBP-1↑, CHOP/DDIT3↑, GRP78/BiP↑, *chemoPv↑,

5114-

JG,

Juglone, from Juglans mandshruica Maxim, inhibits growth and induces apoptosis in human leukemia cell HL-60 through a reactive oxygen species-dependent mechanism

-

in-vitro,

AML,

HL-60

IC50 value ∼8 μM

ROS↑, GSH↓, eff↓, cl‑PARP↑, proCasp3↑, proCasp9↑, MMP↓, Cyt‑c↑, Diablo↑,

1918-

JG,

ROS -mediated p53 activation by juglone enhances apoptosis and autophagy in vivo and in vitro

-

in-vitro,

Liver,

HepG2

1-30uM

-

in-vivo,

NA,

NA

4mg/kg

mice were intraperitoneally injected with 10%
dimethyl sulfoxide (DMSO) or JG (4 mg/kg) every other day for ten
times in tota

TumCG↓, TumCP↓, Apoptosis↑, TumAuto↑, AMPK↑, mTOR↑, P53↑, H2O2↑, ROS↑, toxicity↝, p62↓, DR5↑, Casp8↑, PARP↑, cl‑Casp3↑,

8087-

KAE,

Therapeutic Importance of Kaempferol in the Treatment of Cancer through the Modulation of Cell Signalling Pathways

-

Review,

Var,

NA

TumCCA↓, ROS↝, Apoptosis↑, TumCP↑, TumMeta↓, angioG↓, PI3K↓, EMT↓, Snail↓, E-cadherin↓, N-cadherin↓, MMP2↓, Casp9↑, Casp7↑, PARP↑, Apoptosis↑, *ROS↓, Hif1a↓, p‑Akt↓, P53↑, cMyc↓, Glycolysis↓, PKM2↓, miR-339-5p↝, BioAv↓,

8095-

KAE,

Kaempferol: A Key Emphasis to Its Anticancer Potential

-

Review,

Var,

NA

*AntiBio↑, *Inflam↓, *AntiTum↓, *antiOx↑, *cardioP↑, *neuroP↑, *AntiDiabetic↑, Risk↓, TumCCA↑, EMT↓, PI3K↓, Akt↓, MMP2↓, Casp3↑, Casp7↑, Casp9↑, PARP↑, *ROS↓, angioG↓, *BioAv↑, BioAv↑, selectivity↑, GLUT1↓, MCT1↓, ROS↓, ROS↑, Trx↓, Cyt‑c↑, MMP↓, miR-21↓, SOCS-3↓, STAT3↓, CDK1↓, CycB/CCNB1↑, HIF-1↓, JAK1↑, PTEN↑,

8097-

KAE,

The Phenolic compound Kaempferol overcomes 5-fluorouracil resistance in human resistant LS174 colon cancer cells

-

in-vitro,

CRC,

LS174T

ChemoSen↑, tumCV↓, Apoptosis↑, TumCCA↑, ROS↓, Casp3↑, Casp9↑, cl‑PARP↑, p‑STAT3↓, Akt↓, FOXO3↓, NF-kB↓, VEGF↓, TS↓, TK1↓,

8102-

KAE,

Kaempferol inhibits gastric cancer tumor growth: An in vitro and in vivo study

-

vitro+vivo,

GC,

MKN-28

-

vitro+vivo,

GC,

SGC-7901

-

in-vitro,

GC,

GES-1

TumCP↓, TumCCA↑, Apoptosis↑, selectivity↑, TumVol↓, CycB/CCNB1↓, CDK1↓, CDC25↓, Bcl-2↓, BAX↑, Casp3↑, Casp9↑, cl‑PARP↑, p‑Akt↓, p‑ERK↓, COX2/PTGS2↓,

8060-

KAE,

Mechanisms underlying apoptosis-inducing effects of Kaempferol in HT-29 human colon cancer cells

-

in-vitro,

CRC,

HT-29

TumCCA↑, DNAdam↑, ChrCon↑, cl‑Casp9↑, cl‑Casp3↑, cl‑Casp7↑, cl‑PARP↑, MPT↑, Cyt‑c↑, Bcl-xL↓, Bak↑, Akt↓, BAD↑, Casp↑, MMP↓,

8072-

KAE,

Natural defense against colorectal cancer: the effects of kaempferol on epigenetics, apoptosis, inflammation, oxidative stress, and cell proliferation

-

Review,

CRC,

NA

AntiCan↑, TumCP↓, TumCI↓, Inflam↓, angioG↓, ROS↑, Apoptosis↑, ChemoSen↑, Risk↓, *antiOx↑, *Inflam↓, *AntiBio↑, *cardioP↑, *neuroP↑, selectivity↑, PUMA↑, Cyt‑c↑, cl‑Casp3↑, cl‑PARP↑, Apoptosis↑, NF-kB↓, COX2/PTGS2↓, CC(CDKs/cyclins)↓, TumCCA↑, BioAv↓, Synergy↑, DR4↑, DR5↑, Casp3↑, Casp9↑, Casp7↑, TumCP↓, TumCI↓, TumAuto↑, mtDam↑, P53↑, MAPK↑, *lipid-P↓, *TAC↑, *Catalase↑, *SOD↑, *GPx↑, *NRF2↑,

8075-

KAE,

QC,

Systematic review on anticancer potential of Kaempferol and quercetin against lung, breast, and colorectal cancers with emphasis on in vitro and in vivo studies

-

Review,

Var,

NA

tumCV↓, Apoptosis↑, TumCP↓, TumCMig↓, PI3K↓, Akt↓, MAPK↓, NF-kB↓, P53↑, Bcl-2↓, PARP↑, ERK↓, IQGAP3↓, γH2AX↑, cl‑Casp3↑, cl‑Casp9↑, Rho↓, Rac1↓, MMP2↓, MMP9↓, CTSB↓, CTSD↓, O-Glc↓, SERPINH1/HSP47↓, EMT↓, angioG↓, EGF↓, VEGFR2/KDR/Flk1↓, RadioS↑,

8081-

KAE,

The Anticancer Effects and Therapeutic Potential of Kaempferol in Triple-Negative Breast Cancer

-

Review,

BC,

NA

*antiOx↓, *Inflam↓, *neuroP↓, *AntiCan↑, DNAdam↓, Casp3↑, Casp9↑, p‑AMT/GCST/T-protein↑, ROS↑, NRF2↑, Apoptosis↑, cl‑PARP↓, BAX↑, Bcl-2↓, TumCCA↓, angioG↓, MMP3↓, MMP9↓, ChemoSen↑, BioAv↓, Glycolysis↓, cl‑PARP↑, Ca+2↑, MMP↓, ER Stress↑, GRP78/BiP↑, CHOP/DDIT3↑, ATF6↑, angioG↓, VEGF↓, Hif1a↓, chemoP↑, *ROS↓, NRF2↑, BioAv↑,

8152-

lamb,

TRAIL/rTRAIL,

Lambertianic Acid Sensitizes Non-Small Cell Lung Cancers to TRAIL-Induced Apoptosis via Inhibition of XIAP/NF-κB and Activation of Caspases and Death Receptor 4

-

in-vitro,

NSCLC,

A549

-

in-vitro,

Lung,

H1299

TumCD↑, cl‑PARP↑, Casp3↑, Casp8↑, Casp9↑, Bcl-2↓, cFLIP↓, XIAP↓, BID↑, DR4↑, p‑NF-kB↓, p‑IκB↓,

8151-

lamb,

Suppression of STAT3 Phosphorylation and RelA/p65 Acetylation Mediated by MicroRNA134 Plays a Pivotal Role in the Apoptotic Effect of Lambertianic Acid

-

in-vitro,

BC,

MCF7

-

in-vitro,

Pca,

DU145

-

in-vitro,

Pca,

PC3

-

in-vitro,

BC,

MDA-MB-231

TumCCA↑, cl‑PARP↑, p‑STAT3↓, NF-kB↓, XIAP?, survivin↓, Bcl-2↓, Bcl-xL↓, VEGF↓, COX2/PTGS2↓, cMyc↓, IL6↓, TNF-α↓, ac‑p65↑, Obesity↓, miR-134↑,

8150-

lamb,

Reactive oxygen species dependent phosphorylation of the liver kinase B1/AMP activated protein kinase/ acetyl-CoA carboxylase signaling is critically involved in apoptotic effect of lambertianic acid in hepatocellular carcinoma cells

-

in-vitro,

HCC,

HepG2

-

in-vitro,

HCC,

SK-HEP-1

lipidLev↓, TumCCA↑, cl‑Casp3↑, cl‑PARP↑, AMPK↑, Akt↓, mTOR↓, Bcl-2↓, Bcl-xL↓, COX2/PTGS2↓, ROS↑, eff↓, p‑STK11/LKB1↑, p‑ACC↑, *Obesity↓, *Stress↓, *antiAll↑, tumCV↓, selectivity↑, TumCP↓, *antiAll↑,

8148-

lamb,

Anti-Cancer Effect of Lambertianic Acid by Inhibiting the AR in LNCaP Cells

-

in-vitro,

Pca,

LNCaP

*antiAll↑, *Bacteria↓, AR↓, PSA↓, TumCCA↑, CDK4↓, CDK6↓, cycD1/CCND1↓, P53↑, P21↑, p27/CDKN1B↓, Apoptosis↑, cl‑Casp9↑, cl‑Casp3↑, cl‑PARP↑, BAX↑, Bcl-2↓, Dose↝,

Showing Research Papers: 251 to 300 of 460
Prev Page 6 of 10 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 460

Pathway results for Effect on Cancer / Diseased Cells:

NA, unassigned(tgid=0) ⓘ

NA↓, 2, NA↑, 2, NA⇅, 1, NA?, 1,

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 2, antiOx↑, 2, ARE/EpRE↑, 1, Catalase↓, 5, Catalase↑, 2, Copper↑, 1, ENOX2↓, 1, Fenton↑, 3, GPx↓, 3, GPx↑, 2, GPx1↓, 1, GPx4↓, 3, GSH↓, 30, GSH↑, 5, i-GSH∅, 1, GSH/GSSG↓, 2, GSR↓, 2, GSR↑, 2, GSSG↑, 2, GSTs↓, 2, GSTs↑, 2, H2O2↑, 5, i-H2O2↑, 1, HO-1↓, 10, HO-1↑, 11, HO-2↓, 1, Iron↑, 2, i-Iron↑, 1, Keap1↓, 2, lipid-P?, 1, lipid-P↓, 1, lipid-P↑, 10, MDA↓, 2, MDA↑, 4, MPO↓, 1, NOX4↑, 1, NQO1↓, 3, NQO1↑, 1, NRF2↓, 18, NRF2↑, 18, p‑NRF2↑, 1, Prx↓, 1, Prx4↑, 1, PrxII↓, 1, RNS↑, 2, ROS?, 3, ROS↓, 20, ROS↑, 231, ROS⇅, 10, ROS↝, 1, ROS∅, 2, i-ROS↑, 2, mt-ROS↑, 7, SOD↓, 6, SOD↑, 4, SOD1↓, 1, SOD1↑, 1, SOD2↓, 4, SOD2↑, 1, TAC↑, 2, Thiols↓, 1, Trx↓, 2, ox-Trx1↑, 1, TrxR↓, 7, TrxR1↓, 6, VitC↓, 1, VitE↓, 1, xCT/SLC7A11↓, 1,

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↓, 1, IronCh↑, 1, Tf↓, 1,

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↑, 1, CDC2↓, 7, CDC25↓, 15, EGF↓, 4, ETC↓, 3, MFN2↑, 1, mitResp↓, 2, MKK7↓, 1, mtDam↑, 20, OCR↓, 3, OCR↑, 1, OXPHOS↓, 5, mt-OXPHOS↓, 2, PDH↓, 2, PDH↝, 1, p‑PDH↑, 1, PINK1↑, 3, SDH↓, 1, SIRT3↓, 1, SIRT3↑, 2,

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 1, 5LO↓, 1, ACC↑, 3, p‑ACC↑, 2, ALAT↓, 4, ALDOA↓, 2, AMP↑, 1, AMPK↓, 2, AMPK↑, 22, p‑AMPK↑, 2, p‑AMT/GCST/T-protein↑, 1, ATP↓, 15, ATP↑, 1, citrate↓, 1, CPT1A↓, 1, ECAR↝, 1, ENO1↓, 3, FASN↓, 4, FASN↑, 1, FBPase↑, 1, GAPDH↓, 2, glucoNG↓, 1, glucoNG↑, 1, glucose↓, 2, GlucoseCon↓, 8, GlutMet↓, 1, Glycolysis↓, 23, GSK‐3β↓, 9, GSK‐3β↑, 5, p‑GSK‐3β↓, 8, H2S↑, 1, HK1↓, 1, HK2↓, 13, HMG-CoA↓, 1, lactateProd↓, 12, LDHA↓, 6, LDL↓, 2, lipidLev↓, 1, MCT4↓, 1, NAD↓, 2, NADPH↓, 1, NADPH↑, 2, O-Glc↓, 1, PCK1↓, 1, PDK1 / PDPK1?, 2, PDK1 / PDPK1↓, 8, PDKs↓, 1, PFK↓, 3, PFK2?, 1, PGK1↓, 1, PKM2↓, 13, PKM2∅, 1, PLA2↓, 1, PPP↓, 1, SIRT1↓, 9, SIRT1↑, 2, TCA↓, 3, TS↓, 1, Warburg↓, 5, β-oxidation↓, 2,

Cell Death(tgid=5) ⓘ

14-3-3 proteins↓, 1, AIF↑, 13, APAF1↑, 11, Apoptosis↓, 9, Apoptosis↑, 253, mt-Apoptosis↑, 2, ASC↓, 1, BAD↓, 3, BAD↑, 21, p‑BAD↓, 2, Bak↓, 1, Bak↑, 14, BAX↓, 4, BAX↑, 146, BAX↝, 1, BAX∅, 1, Bax:Bcl2↑, 44, Bcl-2↓, 167, Bcl-2↑, 6, Bcl-2↝, 1, Bcl-2∅, 2, cl‑Bcl-2↓, 1, cl‑Bcl-2↑, 1, Bcl-xL↓, 53, Bcl-xL↑, 1, Bcl-xL∅, 1, BID↑, 11, cl‑BID↑, 2, BIM↑, 10, Casp↑, 38, Casp↝, 2, cl‑Casp↑, 2, Casp1↓, 1, Casp1↑, 2, Casp10↑, 3, Casp12?, 1, Casp12↑, 3, Casp2↑, 1, Casp3?, 1, Casp3↓, 3, Casp3↑, 215, Casp3↝, 1, Casp3∅, 1, cl‑Casp3↓, 1, cl‑Casp3↑, 94, cl‑Casp3⇅, 1, cl‑Casp3∅, 1, proCasp3↓, 4, proCasp3↑, 5, Casp6↓, 1, Casp6↑, 3, Casp7↑, 29, cl‑Casp7↑, 11, Casp8↓, 2, Casp8↑, 60, Casp8∅, 2, cl‑Casp8↑, 24, proCasp8↓, 1, proCasp8↑, 4, Casp9?, 1, Casp9↓, 2, Casp9↑, 127, Casp9∅, 1, cl‑Casp9↓, 1, cl‑Casp9↑, 38, proCasp9↓, 1, proCasp9↑, 4, cFLIP↓, 8, Cyt‑c↓, 3, Cyt‑c↑, 126, Cyt‑c↝, 2, Cyt‑c?, 1, Diablo↑, 12, DR5↑, 30, Endon↑, 1, FADD↑, 9, Fas↓, 1, Fas↑, 21, FasL↑, 10, Ferroptosis↓, 1, Ferroptosis↑, 5, GRP58↓, 1, GSDME↑, 1, cl‑GSDME↑, 1, HEY1↓, 2, IAP1↓, 11, IAP2/BIRC3↓, 5, IAP2/BIRC3↑, 1, cl‑IAP2/BIRC3↑, 1, ICAD↓, 2, ICD↑, 1, iNOS↓, 12, Mcl-1?, 1, Mcl-1↓, 35, Mcl-1↑, 1, cl‑Mcl-1↑, 1, MDM2↓, 11, MDM2↑, 1, p‑MDM2↓, 2, MLKL↑, 2, p‑MLKL↓, 1, MOMP↓, 1, MOMP↑, 1, Necroptosis↑, 4, necrosis↑, 7, NOXA↑, 5, p38↓, 2, p38↑, 18, p‑p38↓, 4, p‑p38↑, 10, PDCD4↑, 1, PUMA↑, 10, Pyro↑, 4, RIP1↓, 2, RIP3↓, 1, RIP3↑, 2, p‑RIP3↑, 2, survivin↓, 73, TNFR 1↑, 2, TRAIL↑, 3, TRAILR↑, 2, TumCD↓, 1, TumCD↑, 23, XIAP?, 1, XIAP↓, 35, XIAP↑, 1, YAP/TEAD↓, 1,

Kinase & Signal Transduction(tgid=6) ⓘ

Akt?, 1, Akt↓, 118, Akt↑, 4, p‑Akt↓, 49, AKT1↓, 1, BRAF↓, 2, CaMKII ↓, 2, CIP2A↓, 1, CK2↓, 4, cMET↓, 1, p‑cMET↑, 1, p‑CREB↓, 1, cSrc↓, 6, DYRK1B↓, 1, EF-1α↓, 1, EGFR↓, 29, EGFR↑, 2, p‑EGFR↓, 1, ERK↓, 36, ERK↑, 12, p‑ERK↓, 21, p‑ERK↑, 5, FGFR1↓, 3, FGFR2↓, 1, HER2/EBBR2↓, 14, HGF/c-Met↓, 3, IGF-1R↓, 4, IGF-1R↑, 1, IGFR↓, 2, IKKα↓, 7, IKKα↑, 1, ILK↓, 1, IκB↓, 3, IκB↑, 1, p‑IκB↓, 1, JAK↓, 2, JAK1?, 1, JAK1↓, 8, JAK1↑, 1, p‑JAK1↓, 2, JAK2↓, 10, p‑JAK2↓, 5, JNK↓, 2, JNK↑, 23, p‑JNK↓, 2, p‑JNK↑, 10, cl‑JNK↑, 1, MAPK↓, 29, MAPK↑, 10, MAPK↝, 1, p‑MAPK↓, 1, p‑MAPK↑, 1, MEK↓, 4, p‑MEK↓, 1, p‑MEK↑, 1, MKK4↓, 1, mTOR↓, 56, mTOR↑, 4, mTOR↝, 1, p‑mTOR↓, 13, mTORC2↓, 4, p70S6↓, 2, p70S6↑, 1, P70S6K↓, 3, p‑P70S6K↓, 2, PDGFR-BB↓, 1, p‑PDGFR-BB↓, 1, PI3K↓, 84, PI3K↑, 1, p‑PI3K↓, 8, PI3K/Akt↓, 3, PI3k/Akt/mTOR↓, 1, PIAS-3↑, 1, PKA↓, 1, PKCδ↓, 8, cl‑PKCδ↑, 1, PP2A↑, 1, PRAS40↑, 1, PTEN↓, 2, PTEN↑, 21, p‑PTEN↓, 1, Raf↓, 4, c-Raf↓, 1, RAS↓, 11, RSK2/RPS6KA3/p90RSK2↓, 1, RTK-RAS↓, 1, SHP1↑, 4, Sp1/3/4↓, 7, Src↓, 3, p‑Src↓, 1, STAT↓, 2, p‑STAT↓, 1, STAT3↓, 58, STAT3↑, 2, p‑STAT3↓, 18, p‑STAT3↑, 1, STAT5↓, 2, STAT6↓, 2, p‑STAT6↓, 1, STK11/LKB1↑, 1, p‑STK11/LKB1↑, 2, THEM4/CTMP↑, 1, TK1↓, 1, TSC2↑, 1,

Transcription & Epigenetics(tgid=7) ⓘ

ATF1↓, 1, ATF2↓, 1, ATF3↑, 2, ATF4↓, 1, ATF4↑, 15, ATF4↝, 1, CBP↓, 1, cJun↓, 6, cJun↑, 4, cMyc↓, 35, cMyc↑, 1, p‑cMyc↑, 1, DNMT1↓, 7, DNMT3A↓, 2, DNMTs↓, 3, EZH2↓, 2, FOXM1↓, 3, FOXO1↑, 2, FOXO3↓, 3, FOXO3↑, 4, FOXO3↝, 1, p‑FOXO3↓, 1, FOXO4↑, 2, H3↓, 4, H3↑, 2, p‑H3↓, 2, ac‑H3↑, 1, H4↓, 1, H4↑, 1, ac‑H4↑, 1, HATs↓, 4, HATs↑, 1, HDAC↓, 16, HDAC1↓, 4, HDAC2↓, 4, HDAC3↓, 3, HDAC8↓, 1, HES1↓, 2, miR-134↑, 1, miR-139-5p↑, 1, miR-200b↑, 1, miR-205↑, 1, miR-21↓, 5, miR-21↑, 1, miR-21↝, 1, miR-25-5p↓, 1, miR-27a-3p↓, 1, miR-29b↓, 1, miR-339-5p↝, 1, miR-340↑, 1, miR-34a↑, 1, miR-34b-5p↑, 1, miR-384↑, 1, Myc↓, 4, MYCN↓, 1, OCT4↓, 6, other↓, 1, other↑, 1, other⇅, 1, other↝, 7, PhotoS↑, 1, SOX2↓, 3, SOX4↓, 1, SOX4↑, 1, SOX9↓, 1, SUV39H↓, 2, TCF-4↓, 1, TFAP2A↓, 1, tumCV↓, 76, tumCV∅, 1, ZBTB10↑, 1,

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↑, 3, CHOP/DDIT3↑, 36, cl‑CHOP/DDIT3↑, 1, eIF2α↓, 1, eIF2α↑, 6, p‑eIF2α↑, 9, ER Stress↓, 1, ER Stress↑, 53, GRP78/BiP↓, 1, GRP78/BiP↑, 18, HSF1↓, 1, HSP27↓, 5, HSP27↑, 1, HSP27↝, 1, HSP70/HSPA5↓, 9, HSP70/HSPA5↑, 2, HSP70/HSPA5↝, 1, HSP72↓, 1, HSP90↓, 11, HSPs↓, 1, IRE1↑, 6, PDI↑, 1, PERK↑, 9, Proteasome↓, 1, SERPINH1/HSP47↓, 1, UPR↑, 11, XBP-1↓, 2, XBP-1↑, 4, XBP-1↝, 1,

Autophagy & Lysosomes(tgid=9) ⓘ

ATG13↑, 1, ATG16L1↑, 1, ATG3↓, 1, ATG3↑, 4, ATG5↑, 12, ATG7↑, 3, Beclin-1/ATG6↓, 2, Beclin-1/ATG6↑, 20, CTSB↓, 1, CTSD↓, 1, LC3‑Ⅱ/LC3‑Ⅰ↓, 1, LC3‑Ⅱ/LC3‑Ⅰ↑, 6, LC3A↑, 1, LC3B↑, 2, LC3B-II↑, 5, LC3I↓, 1, LC3I↑, 1, LC3II↓, 1, LC3II↑, 14, LC3s↑, 1, lysoMP↑, 1, MitoP↑, 1, p62↓, 10, p62↑, 5, PARK2↑, 3, RUBCN↓, 1, SESN2↑, 1, TumAuto↑, 44, TumAuto⇅, 1, ULK1/ATG1↑, 1,

DNA Damage & Repair(tgid=10) ⓘ

8-oxo-dG↑, 1, ATM↑, 1, p‑ATM↑, 1, BRCA1↓, 1, BRCA2↓, 1, DFF45↓, 2, DFF45↑, 3, DNA-PK↑, 1, DNAdam↓, 4, DNAdam↑, 71, DNArepair↓, 4, ERCC1↓, 1, ERCC4/XPF↓, 1, hTERT/TERT↓, 7, Ku70/XRCC6↓, 1, MGMT↓, 1, p16↑, 1, P53?, 1, P53↓, 6, P53↑, 81, p‑P53↓, 1, p‑P53↑, 7, ac‑P53↑, 1, p53 Wildtype↓, 1, PARP↓, 22, PARP↑, 85, PARP↝, 4, PARP∅, 1, p‑PARP↑, 6, cl‑PARP↓, 6, cl‑PARP↑, 324, cl‑PARP↝, 1, cl‑PARP∅, 2, proPARP↓, 1, PCNA↓, 21, SIRT6↑, 1, Telomerase↓, 13, TOP1↓, 4, TOP2↓, 3, TOP2↑, 1, TP53↓, 1, TP53↑, 1, TRF2↓, 1, γH2AX↓, 1, γH2AX↑, 12, p‑γH2AX↑, 2,

Cell Cycle & Senescence(tgid=11) ⓘ

CC(CDKs/cyclins)↓, 1, CDK1↓, 20, CDK1↑, 1, p‑CDK1↓, 2, p‑CDK1↑, 1, CDK1/2/5/9↓, 1, CDK2↓, 38, CDK2↑, 3, p‑CDK2↓, 2, CDK4↓, 42, CDK4↑, 1, CDK4/6↓, 1, CDK6↓, 21, CDK6↑, 2, CDK8↓, 1, CHK1↓, 2, CHK1↑, 1, Chk2↓, 3, Chk2↑, 1, ChrCon↑, 1, Cyc↓, 2, cycA1/CCNA1↓, 14, CycB/CCNB1↓, 31, CycB/CCNB1↑, 6, cycD1/CCND1↓, 82, cycD1/CCND1↑, 1, cycD1/CCND1↝, 1, CycD3↓, 4, CycD3↑, 1, cycE/CCNE↓, 26, cycE/CCNE↑, 1, E2Fs↓, 2, GADD45A↓, 1, GADD45A↑, 1, Ki-67↓, 21, MAD↓, 1, mitA↑, 3, p19↑, 1, P21?, 2, P21↓, 6, P21↑, 61, P21↝, 1, p27/CDKN1B↓, 3, p27/CDKN1B↑, 28, pRB↑, 1, p‑pRB↓, 2, p‑RB1↓, 7, cl‑RB1↓, 1, Securin↓, 1, TubPol↓, 1, TumCCA?, 1, TumCCA↓, 7, TumCCA↑, 188, WEE1↑, 2,

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

4E-BP1↓, 1, p‑4E-BP1↓, 1, ALDH↓, 4, Axin2↑, 1, BMI1↓, 1, CD133↓, 2, CD24↓, 2, CD34↓, 1, cFos↓, 6, cFos↑, 1, cMYB↓, 1, CSCs↓, 21, Diff↓, 1, Diff↑, 1, FGF↓, 5, Gli↓, 1, Gli1↓, 5, HH↓, 6, HMGCR↓, 1, IGF-1↓, 8, IGF-2↓, 1, IGFBP1↑, 1, IGFBP3↑, 3, JAG1↓, 1, Ki-67↓, 21, Let-7↑, 1, mTORC1↓, 4, Nanog↓, 3, Nestin↓, 1, NICD↓, 1, NOTCH↓, 10, NOTCH↑, 1, NOTCH1↓, 10, NOTCH1↑, 1, NOTCH2↑, 1, NOTCH3↓, 3, OGFr↑, 1, p300↓, 1, PTCH2↓, 1, SAL↑, 1, SCF↓, 2, Shh↓, 7, Smo↓, 2, STAT1↓, 1, Sufu↑, 1, TAZ↓, 1, TumCG?, 1, TumCG↓, 72, TumCG↑, 3, TumCP↓, 131, TumCP↑, 6, tyrosinase↓, 2, URGCP/URG4↓, 1, Wnt↓, 23, Wnt↑, 1, Wnt/(β-catenin)↓, 3,

Migration(tgid=13) ⓘ

AEG1↓, 1, AntiAg↑, 1, AP-1↓, 5, AP-1↝, 1, AXL↓, 3, BACH1↓, 1, Ca+2↓, 2, Ca+2↑, 27, Ca+2↝, 2, i-Ca+2↑, 1, CAFs/TAFs↓, 2, cal2↓, 1, cal2↑, 1, Cav1↓, 1, Cdc42↓, 2, COL1↓, 1, COL3A1↓, 1, E-cadherin↓, 6, E-cadherin↑, 28, EM↑, 1, EMT↓, 39, EMT↑, 1, EMT↝, 1, EpCAM↓, 3, F-actin↓, 1, FAK↓, 8, p‑FAK↓, 3, Fibronectin↓, 3, GLI2↓, 3, IQGAP3↓, 1, ITGA5↓, 1, ITGB1↓, 1, ITGB3↓, 1, ITGB4↓, 1, KRAS↓, 2, LAMs↓, 1, LEF1↓, 1, MET↓, 3, p‑MET↓, 1, MMP-10↓, 2, MMP1↓, 7, MMP13↓, 1, MMP16↓, 1, MMP2↓, 60, MMP3↓, 7, MMP7↓, 6, MMP9↓, 67, MMPs↓, 24, MMPs↝, 1, MUC4↓, 1, N-cadherin↓, 21, p44↓, 1, PAK1↓, 2, pax↓, 1, p‑pax↓, 1, PDGF↓, 5, Rac1↓, 4, RECK↑, 1, Rho↓, 4, ROCK1↓, 2, Slug↓, 8, Smad1↓, 1, p‑SMAD2↓, 1, SMAD3↓, 3, SMAD3↑, 1, p‑SMAD3↓, 1, p‑SMAD4↓, 1, Snail?, 1, Snail↓, 22, TET1↓, 1, TET1↑, 2, TGF-β↓, 10, TGF-β↑, 1, TIMP1↑, 10, TIMP2↑, 10, TIMP3↑, 1, TRIB3↑, 1, TSC1↑, 1, TSP-1↑, 2, TumCA↑, 1, TumCI?, 1, TumCI↓, 53, TumCMig↓, 49, TumMeta?, 1, TumMeta↓, 42, TumMeta↑, 2, Twist↓, 14, Tyro3↓, 1, uPA↓, 14, uPAR↓, 1, Vim↓, 22, Vim↑, 1, Zeb1↓, 7, Zeb1↑, 1, ZEB2↓, 2, α-tubulin↓, 2, α-tubulin↑, 1, β-catenin/ZEB1↓, 32, β-catenin/ZEB1↑, 1,

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 70, angioG↑, 1, CD31/PECAM-1↓, 2, ECM/TCF↓, 1, Endoglin↑, 3, eNOS↓, 2, HIF-1↓, 3, Hif1a↓, 40, NO↓, 1, NO↑, 4, VCAM-1↓, 2, VEGF↓, 79, VEGF↑, 1, VEGF↝, 1, VEGFR1↓, 2, VEGFR2/KDR/Flk1↓, 16, p‑VEGFR2/KDR/Flk1↓, 1,

Barriers & Transport(tgid=15) ⓘ

BBB↑, 4, BBB∅, 1, CLDN1↓, 2, CLDN1↑, 1, CLDN2↓, 1, EPR↑, 1, GLUT1↓, 9, GLUT1↑, 1, GLUT2↓, 1, GLUT4↓, 1, IBI↑, 1, MMP↓, 135, MMP↑, 2, MMP∅, 1, MPT↑, 8, NHE1↓, 1, OCLN↑, 1, SVCT-2↓, 1, SVCT-2∅, 1, TJ↑, 1, TRPM7↓, 1, TRPV1↑, 2, ZO-1↑, 2,

Immune & Inflammatory Signaling(tgid=16) ⓘ

CB2 / CNR2↑, 1, CD25+↑, 1, CD4+↑, 1, CD44↓, 9, cDC2↓, 4, p‑cDC2↓, 2, COX1↓, 1, COX2/PTGS2↓, 61, COX2/PTGS2↑, 2, COX2/PTGS2↝, 1, CXCR2↓, 1, CXCR4↓, 10, CXCR4↑, 1, DR4↑, 9, DR4∅, 1, FOXP3↑, 1, Gal-3↓, 1, HMGB1↓, 2, ICAM-1↓, 2, IFN-γ↓, 2, IFN-γ↑, 1, IL1↓, 1, IL1↑, 1, IL10↓, 2, IL12↓, 1, IL1α↓, 1, IL1β↓, 10, IL2↑, 3, IL4↓, 1, IL4↑, 1, IL6↓, 27, IL8↓, 4, Imm↑, 4, Imm↝, 2, Inflam↓, 21, LTA/TNF-β↑, 1, M2 MC↓, 1, MCP1/CCL2↓, 1, MCT1↓, 1, MIP2↓, 1, mPGES-1↓, 1, NF-kB↓, 101, NF-kB↑, 4, NF-kB↝, 1, p‑NF-kB↓, 2, p‑NF-kB↑, 2, NK cell↑, 1, NLRP3↓, 1, NLRP3↑, 1, NOD1↓, 1, p50↓, 1, p65↓, 6, p‑p65↓, 2, ac‑p65↓, 1, ac‑p65↑, 1, PD-1↓, 3, PD-1↝, 1, PD-L1↓, 4, PD-L1↑, 1, PGE2↓, 14, PSA↓, 6, RAGE↓, 1, SOCS-3↓, 1, T-Cell↑, 1, T-Cell↝, 1, TCF↓, 1, TCF↑, 1, TLR4↓, 4, TLR4↝, 1, TNF-α↓, 26, TNF-α↑, 4, TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 2,

Cellular Microenvironment(tgid=17) ⓘ

ADAM17↓, 1, IM↓, 1, pH↑, 1,

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 1, SYN1↑, 1,

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AR↓, 15, ER-α36↓, 2, ERα/ESR1↓, 1, GR↝, 1, PPARα↓, 2, PPARγ↓, 1, PPARγ↑, 3,

Drug Metabolism & Resistance(tgid=21) ⓘ

ABC↓, 1, ABCG2↓, 3, BioAv↓, 27, BioAv↑, 31, BioAv↝, 9, BioEnh↑, 5, ChemoSen?, 1, ChemoSen↓, 1, ChemoSen↑, 101, CompStab↓, 1, CompStab↑, 2, CompStab↝, 2, CYP1A1↓, 1, CYP1A1↑, 1, CYP3A4↓, 2, Dose?, 2, Dose↓, 2, Dose↑, 4, Dose⇅, 1, Dose↝, 38, Dose∅, 10, eff↓, 83, eff↑, 66, eff↝, 6, eff∅, 1, GSTA1↑, 1, GSTP1/GSTπ↓, 1, Half-Life↓, 7, Half-Life↑, 1, Half-Life↝, 11, MDR1↓, 4, MRP1/ABCC1↓, 5, P-gp/ABCB1↓, 10, P-gp/ABCB1↑, 1, P450↓, 3, RadioS?, 1, RadioS↑, 30, selectivity↓, 1, selectivity↑, 93, Synergy↑, 73, TET2↑, 1,

Clinical Biomarkers(tgid=22) ⓘ

AFP↓, 2, ALAT↓, 4, ALP↓, 2, AR↓, 15, ascitic↓, 1, AST↓, 3, BRAF↓, 2, BRCA1↓, 1, CEA↓, 2, CRP↓, 1, E6↓, 2, E7↓, 2, EGFR↓, 29, EGFR↑, 2, p‑EGFR↓, 1, ERα/ESR1↓, 1, EZH2↓, 2, Ferritin↓, 1, FOXM1↓, 3, HER2/EBBR2↓, 14, hTERT/TERT↓, 7, IL6↓, 27, KRAS↓, 2, LDH↓, 2, LDH↑, 4, LDH↝, 1, i-LDH↓, 1, Myc↓, 4, NSE↓, 1, PD-L1↓, 4, PD-L1↑, 1, PSA↓, 6, RAGE↓, 1, TP53↓, 1, TP53↑, 1, TRIB3↑, 1,

Functional Outcomes(tgid=23) ⓘ

AntiCan↓, 1, AntiCan↑, 31, antiCG↓, 1, antiD↑, 1, antiNeop↑, 2, AntiTum↓, 2, AntiTum↑, 12, cachexia↓, 2, cardioP↑, 5, CardioT↑, 1, chemoP↑, 17, chemoPv↑, 14, ChemoSideEff↓, 2, hepatoP↓, 1, hepatoP↑, 7, neuroP↑, 5, NP/CIPN↓, 1, Obesity↓, 1, OS↑, 10, Pain↓, 2, QoL↑, 2, radioP↑, 3, Remission↑, 1, RenoP↑, 8, Risk↓, 10, toxicity?, 1, toxicity↓, 12, toxicity↑, 4, toxicity↝, 9, TumVol↓, 22, TumVol↑, 1, TumW↓, 9, Weight↑, 1, Weight∅, 1, Wound Healing↓, 1,

Infection & Microbiome(tgid=24) ⓘ

AntiBio↓, 1, AntiP↑, 1, Bacteria↓, 3, GutMicro↑, 3, GutMicro↝, 1,

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 1, Ingr↝, 2,
Total Targets: 1014

Pathway results for Effect on Normal Cells:

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx?, 1, antiOx↓, 3, antiOx↑, 41, i-antiOx↑, 1, Catalase↑, 22, GPx↑, 14, GPx1↑, 1, GSH↑, 15, GSR↑, 2, GSSG∅, 1, GSTs↑, 9, H2O2↓, 1, HDL↑, 1, HO-1↓, 1, HO-1↑, 11, Keap1↑, 1, Keap1↝, 1, lipid-P↓, 11, MDA↓, 9, MPO↓, 1, NADH↓, 1, NOX4↓, 1, Nrf1↑, 1, NRF2↓, 1, NRF2↑, 23, Prx↑, 1, RNS↓, 3, ROS↓, 44, ROS↑, 2, ROS∅, 4, mt-ROS?, 1, SOD↓, 1, SOD↑, 21, SOD1↑, 2, SOD2↑, 2, TAC↑, 2, TBARS↓, 1, uricA↓, 1, VitC↑, 1, VitE↑, 1,

Metal & Cofactor Biology(tgid=2) ⓘ

Mitochondria & Bioenergetics(tgid=3) ⓘ

Insulin↑, 2, PGC-1α↑, 1, PGC-1α↝, 1,

Core Metabolism/Glycolysis(tgid=4) ⓘ

15-LOX/ALOX15↓, 1, 5LO↓, 2, ALAT↓, 4, AMPK↑, 2, ATP↑, 3, GAPDH↑, 1, glucose↓, 4, glucose↝, 1, GSK‐3β↓, 2, LDL↓, 4, lipidLev↓, 1, NAD↑, 1, NADPH↑, 2, SIRT1↑, 2,

Cell Death(tgid=5) ⓘ

AIF↓, 1, Apoptosis↓, 5, Apoptosis∅, 1, mt-Apoptosis↓, 1, BAX↓, 5, Bax:Bcl2↓, 1, Bax:Bcl2↑, 2, Bcl-2↑, 4, Casp↓, 1, Casp1↓, 1, Casp12↓, 1, Casp3?, 1, Casp3↓, 7, Casp3↑, 1, Casp3∅, 1, cl‑Casp3↓, 1, cl‑Casp3↑, 1, Casp8↑, 1, cl‑Casp8↑, 2, Casp9↓, 1, Casp9↑, 1, Casp9∅, 1, cl‑Casp9↓, 1, cl‑Casp9↑, 1, Cyt‑c↓, 4, Cyt‑c∅, 1, Fas↑, 2, iNOS↓, 9, iNOS↑, 1, p38↓, 3,

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 1, Akt↑, 1, p‑Akt↑, 1, Akt2↓, 1, ERK↓, 1, ERK↑, 1, IGF-1R↓, 1, IKKα↓, 1, IκB?, 1, JAK↓, 1, JNK↓, 3, JNK↑, 1, p‑JNK↓, 2, MAPK↓, 4, MAPK↑, 1, mTOR↓, 1, mTOR↑, 1, PDGFR-BB↓, 1, PI3K↓, 2, PI3K↑, 1, PKCδ↓, 1, STAT3↑, 1, p‑STAT3↑, 1, STAT6↓, 1,

Transcription & Epigenetics(tgid=7) ⓘ

p‑cMyc↑, 1, HOTAIR↑, 1, other↓, 2, other↑, 1, other↝, 1, tumCV↓, 1,

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 1, ER Stress↓, 1, GRP78/BiP↓, 1, HSP70/HSPA5↑, 1, IRE1↓, 1, PERK↓, 1, UPR↓, 1,

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↑, 1, LC3II↑, 1, p62↑, 1,

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 1, p16↓, 1, P53↓, 3, P53↑, 2, PARP↓, 3, PARP↑, 1, PARP∅, 1, p‑PARP↓, 1, cl‑PARP↓, 2, cl‑PARP↑, 2, PARP1↓, 1,

Cell Cycle & Senescence(tgid=11) ⓘ

CDK2↓, 1, cycA1/CCNA1↓, 1, cycE/CCNE↑, 1, E2Fs↑, 1, P21↓, 2, P21↑, 3, TumCCA↑, 3,

Migration(tgid=13) ⓘ

AntiAg↑, 5, AP-1↓, 1, Ca+2?, 1, Ca+2↓, 2, Ca+2↝, 1, MLC2/MYL9↝, 1, MMP13↓, 2, MMP2↓, 1, MMP3↓, 1,

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 1, E-sel↓, 1, Hif1a↓, 2, NO↓, 5, NO↑, 1, VCAM-1↓, 2, VEGF↓, 1,

Barriers & Transport(tgid=15) ⓘ

BBB↑, 5, GastroP↑, 2, GLUT1↓, 1, MMP↓, 3, MMP↑, 3, MMP∅, 1, MUC5AC↓, 1, OCLN↝, 1, SVCT-2↑, 1, TJ↑, 1, TRPA1↑, 1, TRPC1↓, 1, TRPV1↑, 1,

Immune & Inflammatory Signaling(tgid=16) ⓘ

CCL11↓, 1, CD4+↑, 1, CD8+↑, 1, COX1↓, 3, COX2/PTGS2↓, 16, COX2/PTGS2↑, 1, IL10↓, 2, IL10↑, 1, IL17↓, 1, IL18↓, 1, IL1β↓, 9, IL6↓, 14, IL6↑, 1, IL8↓, 1, Imm↑, 4, Imm⇅, 1, Inflam↓, 49, pol-M2 MC↑, 1, MCP1/CCL2↓, 1, MyD88↓, 1, NeuroI↓, 1, NF-kB↓, 18, NLRP3↓, 1, PAF↓, 1, PGE2↓, 4, PGE2↑, 1, PSA∅, 1, Th1 response↓, 1, Th2↑, 2, TLR1↓, 1, TLR4↓, 1, TNF-α↓, 20, β-HEX↓, 1,

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↑, 1, AChE↓, 5, BChE↓, 2, BDNF↑, 2, MAOA↓, 1, NGF↑, 1,

Protein Aggregation(tgid=19) ⓘ

Aβ↓, 6, BACE/β-secretase↓, 2, tau↓, 2, p‑tau↓, 2,

Hormonal & Nuclear Receptors(tgid=20) ⓘ

Estro↓, 1, PPARα↑, 1, PPARα↝, 1, PPARγ↓, 1, testos↑, 1,

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 16, BioAv↑, 23, BioAv↝, 9, BioAv∅, 1, BioEnh↑, 1, CompStab↑, 1, Dose↝, 4, Dose∅, 1, eff↑, 6, GSTA1↑, 1, Half-Life↑, 1, Half-Life↝, 7, Half-Life∅, 2, P450↑, 1, Synergy↑, 4,

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 4, ALP↓, 2, AST↓, 5, BG↓, 1, BP↓, 4, creat↓, 1, CRP↓, 3, hs-CRP↓, 1, IL6↓, 14, IL6↑, 1, LDH↓, 4, LDH↑, 1, NOS2↓, 1, PSA∅, 1,

Functional Outcomes(tgid=23) ⓘ

Analgesic↑, 2, AntiAge↑, 3, antiAll↑, 14, AntiArt↑, 7, AntiCan↑, 8, AntiDiabetic↑, 9, antiPs↑, 2, AntiTum↓, 1, AntiTum↑, 3, cardioP↑, 15, chemoP↑, 7, chemoPv↑, 2, cognitive↑, 3, hepatoP↓, 1, hepatoP↑, 9, memory↑, 3, motorD↓, 1, motorD↑, 1, neuroP↓, 1, neuroP↑, 27, Obesity↓, 6, Pain↓, 4, radioP↑, 3, RenoP↑, 1, Stress↓, 1, Stroke↓, 3, toxicity↓, 24, toxicity↑, 2, toxicity↝, 4, toxicity∅, 4,

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 9, AntiFungal↓, 1, AntiFungal↑, 2, AntiP↓, 1, AntiP↑, 2, AntiViral↑, 10, Bacteria↓, 12, GutMicro↑, 9,

Ingredients & Constituents(tgid=25) ⓘ

Ingr↑, 1, Ingr↝, 4,
Total Targets: 292

Scientific Paper Hit Count for: PARP, poly ADP-ribose polymerase (PARP) cleavage

16 Apigenin (mainly Parsley)
16 Curcumin
15 Fisetin
14 Quercetin
14 Thymoquinone
12 Baicalein
10 EGCG (Epigallocatechin Gallate)
10 Sulforaphane (mainly Broccoli)
8 Honokiol
8 Kaempferol
8 Licochalcone A
8 Shikonin
7 Ashwagandha(Withaferin A)
7 Berberine
7 Capsaicin
7 Emodin
7 Garcinol
7 Magnolol
6 Metformin
6 Boswellia (frankincense)
6 Carnosic acid
6 Chrysin
6 Gambogic Acid
6 isoorientin
6 lambertianic acid
6 Piperlongumine
6 Vitamin C (Ascorbic Acid)
5 doxorubicin
5 Betulinic acid
5 Eugenol
5 Licorice
5 Morin
5 Silymarin (Milk Thistle) silibinin
4 Cisplatin
4 Bufalin/Huachansu
4 α-Bisabolol / Chamomile oil
4 Carvacrol
4 chaetocin
4 Citric Acid
4 Docetaxel
4 Evodiamine
4 Formononetin
4 Fucoidan
4 Ginkgetin
4 Ivermectin
4 Nimbolide
4 Propolis -bee glue
4 Phenethyl isothiocyanate
4 Resveratrol
3 Auranofin
3 Silver-NanoParticles
3 Allicin (mainly Garlic)
3 5-fluorouracil
3 Brucea javanica
3 Thymol-Thymus vulgaris
3 Radiotherapy/Radiation
3 Ellagic acid
3 Ferulic acid
3 HydroxyTyrosol
3 Isobavachalcone
3 phytic acid, Inositol hexakisphosphate
3 Isoliquiritigenin
3 Luteolin
3 Lycopene
3 mebendazole
3 Magnetic Fields
3 Methylsulfonylmethane
3 Propyl gallate
3 α-Santalol/Sandalwood oil
2 1,8-Cineole
2 Artemisinin
2 Berbamine
2 Beta-Caryophyllene
2 temozolomide
2 brusatol
2 Boron
2 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
2 Cichoric acid / Chicoric acid
2 Cinnamon
2 Cucurbitacin
2 Cynaropicrin
2 Dichloroacetate
2 D-limonene
2 Dandelion Root
2 Echinacea
2 Ginkgo biloba-EGb 761
2 Eurycomanone
2 Flaxseed/Linseed
2 Gallic acid
2 Photodynamic Therapy
2 Hyperoside
2 Rutin
2 Indole-3-carbinol
2 isoquercitrin
2 Juglone
2 methylseleninic acid
2 Phenylbutyrate
2 Paclitaxel/Taxol
2 Piperine
2 Rosmarinic acid
2 salinomycin
2 Selenite (Sodium)
2 Ursolic acid
2 Urolithin
1 3-bromopyruvate
1 DTS(dibenzyl trisulphide) from Anamu
1 Anethole/trans-Anethole
1 Fennel Oil/Foeniculum vulgare
1 immunotherapy
1 Atorvastatin
1 Aloe anthraquinones
1 Baicalin
1 almonertinib
1 Bromelain
1 Bullatacin
1 Butyrate
1 Sorafenib (brand name Nexavar)
1 Cat’s Claw
1 Celastrol
1 Chlorogenic acid
1 Chlorophyllin
1 Coenzyme Q10
1 Carvone
1 Dichloroacetophenone(2,2-)
1 Date Fruit Extract
1 Diindolylmethane
1 Fenbendazole
1 Geldanamycin
1 Radicicol/monorden
1 Bortezomib
1 Flaxseed Oil
1 olaparib/LYNPARZA
1 Gemcitabine (Gemzar)
1 Ginkgolic acids
1 Genistein (soy isoflavone)
1 Ginkgolide B
1 Ginger/6-Shogaol/Gingerol
1 Gossypol/AT-101
1 Graviola
1 Hydroxycinnamic-acid
1 hydroxychloroquine
1 isoflavones
1 Isovitexin
1 tumor necrosis factor-related apoptosis-inducing ligand
1 Lapachol
1 Lasiodin
1 low dose naltrexone
1 Linalool
1 Lutein
1 Methylene blue
1 Matrine
1 Dordaviprone; Modeyso
1 Modified Citrus Pectin
1 Chemotherapy
1 Mistletoe/Viscum album Extracts
1 Mushroom Chaga, Inonotus obliquus
1 Myricetin
1 nelfinavir/Viracept
1 Oleuropein
1 Marjoram (Origanum majorana)
1 SonoDynamic Therapy UltraSound
1 Hyperthermia
1 Plumbagin
1 VitK3,menadione
1 Rauwolfia serpentina/Indian Snakeroot
1 buckwheat sprouts
1 Selenium NanoParticles
1 chitosan
1 Folic Acid, Vit B9
1 Osimertinib
1 Adagrasib
1 Terpinen-4-ol / Tea Tree Oil
1 Aflavin-3,3′-digallate

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:239  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

Home Page